News and updates
EHA pays tribute to Professor Jacques-Louis Binet (1932–2024)
EHA would like to pause to acknowledge the passing of Professor Jacques-Louis Binet, a pioneer in clinical and biological research and an exceptional personality in hematology.
From bedside to Brussels: hematology at the forefront of EU health policy
EHA's experts are currently front and center in several important EU initiatives that will help improve conditions for, and patient access to, innovation in hematology.
Addressing immunoglobulin shortages: EHA and EBA’s strategic recommendations at …
In recent years, shortages of immunoglobulins (Ig) have become a growing concern in the European Union (EU).
Update on EU4Health Calls and Contracts for 2024
The European Health and Digital Executive Agency (HaDEA) has published the tentative calendar for the EU4Health program calls and contracts for 2024.
EHA reaffirms commitment to hematology's future with new brand identity
The European Hematology Association (EHA) is thrilled to announce the launch of our new brand identity.
Collaboration with the EMA on Joint Clinical Assessments and Joint Scientific Co…
The European Hematology Association (EHA) welcomes the draft Implementing Act laying down procedural rules for the exchange of information between the Health Technology Assessment (HTA) Coordination Group, the European Commission,…
EHA: Bridging Breakthroughs in Hematology
The European Hematology Association (EHA) has undergone a remarkable transformation over the past two years, positioning itself as a future-ready organization dedicated to addressing the needs of the European hematology…
‘i4MDS’ consortium wins prestigious EHA Innovation Grant
In a significant development, the International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—known as the ‘i4MDS’— has received an esteemed EHA Innovation Grant.
Highlights of the EHA-EMA Joint Symposium on RWE
The fourth EHA-EMA Joint Symposium at EHA2024 brought together investigators, regulators and patients to discuss the use of real world evidence (RWE) in the evaluation of new drugs.
Recap: European Affairs and Hematology at EHA2024
As at previous congresses, the European Affairs track at EHA2024 offered opportunities to learn, exchange, and connect.
Publication of EHA Annual General Meeting 2024 minutes
The 2024 EHA Annual General Meeting (AGM) took place in the vibrant city of Madrid, Spain, on June 14, 2024.
What to expect from European Affairs at EHA2024
European Affairs gives a voice to hematology professionals in Europe.
Streamlining SoHO Management in EU Hospitals
The European Commission's Directorate-General for Health and Food Safety (DG SANTE) is committed to improving the management of Substances of Human Origin (SoHO) in EU hospitals.
The European Parliament adopts the Regulation on Substances of Human Origins (So…
On April 24, the European Parliament gave its final endorsement to the regulation on Substances of Human Origin (SoHO).
Parliament puts final stamp on the European Health data Space
On April 24, the European Parliament gave its final endorsement to the regulation on the European Health Data Space (EHDS).